Research-grade Retatrutide + Cagrilintide Blend — 5 mg Retatrutide + 5 mg Cagrilintide (10 mg total) per vial. ≥ 98% supplier batch specification; selected lots independently tested (99.4% avg across published reports). Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
| Name | Retatrutide + Cagrilintide Blend 10mg |
| Size | 10mg |
| SKU | CP-RC10 |
| Form | Lyophilized powder |
| Category | GLP-1 and Incretin Research Peptides |
| Storage | -20°C lyophilized · 2–8°C reconstituted |
Retatrutide Research Starter Kit — everything needed to begin retatrutide research in one bundle. Includes: retatrutide 10mg (lyophilized, ≥98% purity per supplier batch spec),
Retatrutide is a novel triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. This multi-receptor approach has generated significant research interest